Literature DB >> 19545511

Reconstruction of historical exposures in the US nickel alloy industry and the implications for carcinogenic hazard and risk assessments.

Donna J Sivulka1, Steven K Seilkop.   

Abstract

Recently, various regulatory authorities have been reexamining the potential carcinogenic hazards and risks associated with exposures to nickel and certain nickel compounds. In making their assessments, the authorities have focused on occupational cohorts at facilities where nickel-containing sulfidic ores were processed and where increased lung and nasal cancer risks were found in specific groups of workers. Little attention, however, has been paid to the vast number of workers in nickel-using industries, where no excess respiratory cancer risks have been observed. In this paper, the historical exposures of one such group of workers engaged in the production of nickel alloys are reconstructed, and the implications for cancer risk assessments are analyzed. The results indicate that nickel alloy workers were exposed to insoluble oxidic and metallic nickel species at levels comparable to those found in certain nickel processing cohorts; yet they experienced no increase in respiratory cancer risks. This suggests that extrapolating risks from certain primary nickel producers to other nickel industry sectors may not be appropriate.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19545511     DOI: 10.1016/j.yrtph.2009.01.006

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  2 in total

1.  Evidence of carcinogenicity in humans of water-soluble nickel salts.

Authors:  Tom K Grimsrud; Aage Andersen
Journal:  J Occup Med Toxicol       Date:  2010-04-08       Impact factor: 2.646

Review 2.  Occupational exposure and lung cancer.

Authors:  Dionysios Spyratos; Paul Zarogoulidis; Konstantinos Porpodis; Kosmas Tsakiridis; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Georgios Dryllis; Anastasios Kallianos; Aggeliki Rapti; Chen Li; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2013-09       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.